Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Amarillo Biosciences Inc

+ Add to Watchlist

AMAR:US

0.2150 USD 0.00000.00%

As of 20:10:04 ET on 05/06/2015.

Snapshot for Amarillo Biosciences Inc (AMAR)

Open: 0.2150 Day's Range: 0.2150 - 0.2150 Volume: 4,415
Previous Close: 0.2150 52wk Range: 0.0285 - 0.7600 1-Yr Rtn: +74.09%

Stock Chart for AMAR

No chart data available.
  • AMAR:US 0.2150
  • 1D
  • 1M
  • 1Y
0.2150
Interactive AMAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMAR

Current P/E Ratio (ttm) 0.9450
Estimated P/E(-) -
Relative P/E vs. SPX 0.0515
Earnings Per Share (ttm) 0.2275
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 4.33
Shares Outstanding (M) 20.14
30 Day Average Volume 2,438
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMAR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMAR

Amarillo Biosciences, Inc. develops biologics for the treatment of human and animal diseases. The Company develops oral interferon alpha as a treatment for a variety of conditions, including Sjogren's syndrome, hepatitis B and C, and fibromyalgia syndrome.

Stephen T Chen "Steve"Chairman/President/CEO/COOBernard CohenVP/CFO
More Company Profile & Key Executives for AMAR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement

Press Releases for AMAR

Advertisement
Sponsored Links
Advertisements
sec ||= nil